U.S. Markets close in 6 hrs 25 mins

Allakos Inc. (ALLK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
81.60+0.01 (+0.01%)
As of 9:30AM EDT. Market open.
Sign in to post a message.
  • M
    Mike Fink
    When is this company supposed to have good news? Hard to put a price tag on a biotech company that shares very little news.
    Conference calls with question and answer sessions are nonexistent.
    I don't see any insider buying at these prices.
    Why should someone want to buy shares in this company at this point in time. With approval how long will it take for them to become profitable?
  • A
    Anonymous
    So it looks like the six month lockdown period ending for insiders and venture investors has triggered quite a bit of selling. Having heard nothing negative from the clinical development pipeline, I presume it's this wave of insider selling that's triggering the price collapse. If so, I would expect the share price to stabilize and potentially rally once the wave is over.
  • M
    M
    $QS conversation
    @spacguru " I just looked at 2 of the last deals that
    @ScorpionFund
    added to their short report $ALLK shorted at $60's traded down to $40's now $107. Second $NVRO Shorted 1/21 @ $180 went down to $155 in Feb back to $180."

    Haha these guys are not winners. QS will come ahead and shorts will be burned.
  • M
    M
    $QS conversation
    @spacguru " I just looked at 2 of the last deals that
    @ScorpionFund
    added to their short report $ALLK shorted at $60's traded down to $40's now $107. Second $NVRO Shorted 1/21 @ $180 went down to $155 in Feb back to $180."

    Haha these guys are not winners. QS will come ahead and shorts will be burned.
    Bullish
  • D
    Don
    it's going straight to $27
  • S
    Scott
    Sold my IPO shares yesterday in the high $39's. Will keep a watch on the stock, but having a hard time justifying the current valuation. Float is small and I'm guessing a secondary will be needed at some point as more funds are needed for R&D. Time will tell if my sell was a smart one. Good luck to those continuing to hold ALLK.
  • A
    AIKIDO
    AMRN wooow 50M shorts because of MRC flawed research are in big trouble now, massive covering in coming days, like $AXSM $CRTX. $CCXI. $ALLK $KRTX health care stocks boom
    Bullish
  • R
    Rocketdog
    If u cut the price of this company in half to 45, it is extremely over-valued. Any adverse reactions in a Phase 3 trial and this company will tank. No patient is going to take a medication with a serious adverse event for a non-lethal condition. This is not a Soliris comparable drug even if the phase 3 trials went perfectly because the condition is in no way like PNH. Any market down turn will also send this way down in my opinion. Short until under 2B.
  • D
    Doug
    Positive Phase 2 results and the stock price dives.
  • F
    Fasteddy
    This is a clinical stage company. Not sure why the market would care about “earnings” vs simply milestone progress. As trial results are released, this will go up.
  • R
    Rocketdog
    Complete bubble again. Amazing. This company has phase I results. That's it. What are the odds of approval? 20%? Also, how long are we talking? Three years?
  • S
    Scott
    Was able to get a small amount of ALLK IPO shares through Schwab... Not going to change my life either way, but owning some IPO shares will at least make the day interesting. Good luck ALLK longs...
  • A
    AIKIDO
    RDHL should be up 300% at least for Talicia FDA approval the new SOC for blockbuster drug, like $RETA $ALLK $IOVA $MDGX $IONS double, health care sector is recovering
    Bullish
  • A
    AIKIDO
    BLCM time to BUY for me initial 5K will add more later, institutions are buying now tax loss probably done early, question? Why did Jefferies London presentation cancelled? Something is happening either a partnership or a buyout, like $ALLK $VKTX $IOVA $AXSM $AMRN , health care stocks very undervalued
    Bullish
  • T
    The Knight Trader
    I am not a short on this stock but I do see some major price riggings going on here! To take an advantage of the manipulation, you can use options that close in several months from here.
  • T
    The Knight Trader
    Goldman Sachs and Jefferies LLC and associates are illegally rigging shares here before the announcement of the Phase 2 results. Because they knew what was going to be announced! They are holding all floating shares and through their third party associates. They themselves buying and selling shares so it’s all up to them where the prices go!
  • T
    The Knight Trader
    They had limited the floating shares by buying and selling the most of the floating shares with themselves and manipulating the stock prices. See SCE guidelines.

    “Improperly limiting the number of publicly-available shares; or rigging quotes, prices or trades to create a false or deceptive picture of the demand for a security. Those who engage in manipulation are subject to various civil and criminal sanctions.”
  • C
    Cad
    Ok, I dont get it. they had great clinical trials on a cure to mastocytosis, there are like 1000 recorded cases a year! I can appreciate what theyre trying to accomplish, but I dont see how they ever plan to get investors their money back.
  • R
    Rocketdog
    I'm short on this stock. Not sure how it is worth 5.7B. There are other companies with legit phase 3 trials complete (CCXI) that are valued at 1/3 the cost. The disease (eosinophilic gastritis) isn't even lethal. I think insurance companies are going to balk at paying a high price for a medicine that helps treat a non-lethal disease. They won't "refuse" but they will make the providers fill out 500 pages of forms to get it approved.
  • D
    Doug
    I cashed out @ $64.16. Bought @ $41.
    I like to take my gain, then maybe come back in later at a lower price..
    Not sure what I will do with ALLK., whether I will come back in or not.